JOHNSON & JOHNSON PRIVATE LIMITED

501, Arena Space, Behind Majas Bus Depot, Mumbai, Maharashtra, India

Also known as:

johnson and johnson private limited

Clinical Trials

22 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

42.9%

Phase 4

38.1%

Phase 2

4.8%

Unknown

4.8%

Phase 2/3

3.2%

Not Applicable

1.6%

Trial Status Distribution

Active, not recruiting

33.3%

Completed

34.9%

Not yet recruiting

1.6%

Recruiting

23.8%

Unknown

4.8%

Withdrawn

1.6%

Clinical Trials

Trials sponsored by this organization (63)

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Phase 3

Active, not recruiting

interventional

Jul 2026700 participants

A study to Evaluate the Efficacy and Safety of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Phase 3

Recruiting

interventional

Mar 2026882 participants

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohns Disease

Phase 2/3

Recruiting

interventional

Jan 2026789 participants

A Study of Amivantamab in Addition to Carboplatin and Pembrolizumab Compared With Standard of Care- Platinum, Pembrolizumab and 5-FU Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Phase 3

Recruiting

interventional

Jan 2026500 participants

A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

Phase 4

Recruiting

interventional

Aug 2025100 participants

A Study of the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants with Active Psoriatic Arthritis

Phase 3

Recruiting

interventional

Aug 2025540 participants

A Study to evaluate the safety and efficacy of Guselkumab injected Subcutaneously in Indian Participants for treatment in Psoriatic Arthritis (PsA)

Phase 4

Recruiting

interventional

Aug 2025100 participants

A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

Phase 4

Active, not recruiting

interventional

May 202575 participants

Page 1 of 8

Approvals

No approval data available

News

No news articles found

Back to Organizations